← Eichor
Study identifier: NCT05868863 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Percutaneous Cementoplasty With or Without Screw Fixation

Condition: Interventional Radiology  ·  Sponsor: Centre Hospitalier Universitaire de Saint Etienne

PhaseN/A
Planned participants40
Who can joinAll sexes, 80 Years to no upper limit
Healthy volunteersNo

About this study

Bone pathologies such as fragility fractures and neoplastic bone lesions are frequently encountered in rheumatology. When these lesions affect the pelvis, they are responsible both for pain that is sometimes very disabling, but also for significant functional disorders due to their location. Different methods may be used to treat these lesions. The current challenge is to use less and less invasive techniques such as radio-guided cementoplasty to be able to treat all types of people, especially the most fragile. Among the elderly, the prevalence of these bone pathologies continues to increase due to the aging of the population and the improvement of diagnostic means.

This description comes directly from the study's public registry record.

Talk to the study team

Sylvain GRANGE, MD  ·  (0)477127827  ·  grangesylvain@hotmail.fr

Hella TCHEIR, resident  ·  (0)477127827  ·  hellatcheir@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

CHU Saint-EtienneSaint-Etienne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05868863